AGL
Income statement / Annual
Last year (2023), agilon health, inc.'s total revenue was $4.32 B,
an increase of 59.38% from the previous year.
In 2023, agilon health, inc.'s net income was -$262.80 M.
See agilon health, inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$4.32 B
|
$2.71 B
|
$1.83 B
|
$1.22 B
|
$794.41 M
|
| Cost of Revenue |
$4.25 B |
$2.60 B |
$1.76 B |
$1.12 B |
$765.90 M |
| Gross Profit |
$69.67 M |
$112.29 M |
$76.41 M |
$94.15 M |
$28.51 M |
| Gross Profit Ratio |
0.02 |
0.04 |
0.04 |
0.08 |
0.04 |
| Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$285.76 M
|
$218.95 M
|
$455.82 M
|
$137.29 M
|
$122.83 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$285.76 M
|
$218.95 M
|
$455.82 M
|
$137.29 M
|
$122.83 M
|
| Other Expenses |
$16.04 M |
$24.73 M |
$14.54 M |
$13.53 M |
$12.25 M |
| Operating Expenses |
$285.57 M |
$218.95 M |
$470.37 M |
$150.82 M |
$135.09 M |
| Cost And Expenses |
$4.55 B |
$218.95 M |
$2.23 B |
$1.28 B |
$900.99 M |
| Interest Income |
$0.00 |
$4.53 M |
$6.15 M |
$8.14 M |
$9.07 M |
| Interest Expense |
$6.66 M |
$4.48 M |
$6.15 M |
$8.14 M |
$9.07 M |
| Depreciation &
Amortization |
$20.16 M
|
$13.77 M
|
$14.67 M
|
$14.10 M
|
$41.41 M
|
| EBITDA |
-$167.64 M
|
-$72.41 M
|
-$383.78 M
|
-$40.11 M
|
-$64.21 M
|
| EBITDA Ratio |
-0.04 |
-0.04 |
-0.21 |
-0.03 |
-0.08 |
| Operating Income Ratio
|
-0.05
|
-0.04
|
-0.21
|
-0.05
|
-0.13
|
| Total Other
Income/Expenses Net |
$37.67 M
|
$14.71 M
|
-$32.36 M
|
-$5.67 M
|
-$8.11 M
|
| Income Before Tax |
-$194.46 M |
-$105.69 M |
-$404.60 M |
-$62.34 M |
-$114.69 M |
| Income Before Tax Ratio
|
-0.05
|
-0.04
|
-0.22
|
-0.05
|
-0.14
|
| Income Tax Expense |
$791,000.00 |
$1.18 M |
$886,000.00 |
$865,000.00 |
-$232,000.00 |
| Net Income |
-$262.80 M |
-$106.86 M |
-$405.48 M |
-$63.21 M |
-$114.46 M |
| Net Income Ratio |
-0.06 |
-0.04 |
-0.22 |
-0.05 |
-0.14 |
| EPS |
-0.64 |
-0.26 |
-1.01 |
-0.16 |
-0.29 |
| EPS Diluted |
-0.64 |
-0.26 |
-1.01 |
-0.16 |
-0.29 |
| Weighted Average Shares
Out |
$408.92 M
|
$408.15 M
|
$400.10 M
|
$390.83 M
|
$390.83 M
|
| Weighted Average Shares
Out Diluted |
$408.92 M
|
$408.15 M
|
$400.10 M
|
$390.83 M
|
$390.83 M
|
| Link |
|
|
|
|
|
